This website uses cookies to enhance the user experience.
21st logo
||
Q

QIAGEN NORGE, FILIAL AV QIAGEN AB, SVERIGE NUF988 156 027

Purchase and sale
Norwegian division of foreign business enterprise
Torshamnsgatan 35 SE-164 40 KISTA, Sverige

QIAGEN NORGE, FILIAL AV QIAGEN AB, SVERIGE NUF

Operating
Markedsføring og salg av produker og tjenester innen bioteknologi og tilstøtende områder i Norge.

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Organization

Years since formation
21 years
since May 23, 2005
Type
Norwegian division of foreign business enterprise
VAT registered
Yes
Number of employees
6

Financials

Total operating income 2025
81,643,148
NOK
Annual total result 2025
1,755,034
NOK
Total equity 2025
48,189,086
NOK
Last update: Aug 4, 2026

Management

Board

NameRoleShares
A
AMESTO ACCOUNTHOUSE AS
Norwegian Representative for Foreign Entity-
Contact Person-
Q
QIAGEN AB
Information about the Company in the Home Country-

Others

NameRoleShares
Auditor-
A
AMESTO ACCOUNTHOUSE AS
Accountant-
E
ENORA AS
Accountant-
Last update: Jun 5, 2026

Ownership

No available data

Financials

in NOK

Summary

Year20252024202320222021
Total operating income
81,643,148
73,584,481
441,821,242
420,515,272
443,745,853
Annual Total Result
1,755,034
4,496,032
13,469,794
28,060,375
6,759,006
Total assets
60,065,055
74,116,467
130,912,389
134,725,058
128,221,722
Total liabilities
11,875,968
30,530,924
67,657,817
84,940,280
106,497,318
Total equity
48,189,086
43,585,543
63,254,571
49,784,778
21,724,404

P&L

Year20252024202320222021
Total operating income
81,643,148
73,584,481
441,821,242
420,515,272
443,745,853
Total operating costs
78,565,559
73,429,177
407,088,205
375,458,817
425,524,169
Operating result
3,077,589
155,304
34,733,037
45,056,455
18,221,684
Financial income/costs
12,089
5,820,803
-9,477,368
-9,444,923
-6,907,783
Profit before tax
3,089,678
5,976,107
25,255,669
35,611,532
11,313,901
Total tax & extraordinary income/cost
1,334,644
1,480,075
11,785,875
7,551,157
4,554,895
Annual Total Result
1,755,034
4,496,032
13,469,794
28,060,375
6,759,006

Balance overview

Year20252024202320222021
Total fixed assets
682,303
1,619,718
7,618,848
12,738,785
6,096,748
Total current assets
59,382,752
72,496,749
123,293,541
121,986,273
122,124,974
Total assets
60,065,055
74,116,467
130,912,389
134,725,058
128,221,722
Short term debt
11,875,968
30,530,924
67,657,817
84,940,280
106,497,318
Long term debt
0
0
0
0
0
Total liabilities
11,875,968
30,530,924
67,657,817
84,940,280
106,497,318
Contributed capital
0
0
100,000
100,000
100,000
Retained earnings
48,189,086
43,585,543
63,154,571
49,684,778
21,624,404
Total equity
48,189,086
43,585,543
63,254,571
49,784,778
21,724,404
Total equity and liabilities
60,065,055
74,116,467
130,912,388
134,725,058
128,221,722

Classification

21st company classification
BETA
Industrial large enterprise
Category
Type of organization
Norwegian division of foreign business enterprise
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
G
Main industrial area
Wholesale and retail trade; repair of motor vehicles and motorcycles
46
Activity
Wholesale trade, except of motor vehicles and motorcycles
46.4
Main industrial group
Wholesale of household goods
46.46
Industrial group
Wholesale of pharmaceutical goods
46.460
Industrial group
Wholesale of pharmaceutical goods